Research Atlas · source screening

Daptomycin

An attributable first-pass index of PubMed records whose titles name this governed identity. Records are sorted by publication date, not by evidence strength. Inclusion does not establish efficacy, safety, or a clinical indication.

Title-search results

2,237

Shown with stable PMIDs

25

Search recorded

2026-09-26

Source: NCBI PubMed / MEDLINE · exact query: "Daptomycin"[Title] · up to 25 recent title matches per identity. Each result links to its PubMed record.

1. Effectiveness and safety of daptomycin in pediatrics.

   Enferm Infecc Microbiol Clin (Engl Ed) · 2026 Sep 21 · PMID 42767890 · DOI 10.1016/j.eimce.2026.503272

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

2. An in vitro comparative study of cefiderocol, siderophore-aztreonam and siderophore-daptomycin conjugates against select gram-negative bacteria.

   Bioorg Med Chem · 2026 Sep 11 · PMID 42767140 · DOI 10.1016/j.bmc.2026.118805

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

3. Revisiting the mode of action of daptomycin considering the inoculum effect and a novel liposome-MIC-competition assay.

   Biophys J · 2026 Sep 7 · PMID 42706724 · DOI 10.1016/j.bpj.2026.09.004

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

4. Using a liver-on-chip model to evaluate the effects of vancomycin and daptomycin on host immunometabolism and clearance of intracellular reservoirs of Staphylococcus aureus during bacteremia.

   Antimicrob Agents Chemother · 2026 Sep 2 · PMID 42489713 · DOI 10.1128/aac.00254-26

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

5. Evaluation of Changes in Staphylococcus and Enterococcus Resistance Following Reduced Restrictions on Daptomycin and Linezolid.

   Open Forum Infect Dis · 2026 Sep · PMID 42761570 · DOI 10.1093/ofid/ofag523

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

6. Daptomycin or linezolid versus vancomycin in the treatment of vancomycin-susceptible Enterococcus faecium bloodstream infections (SAVE study).

   Int J Antimicrob Agents · 2026 Sep 1 · PMID 42680005 · DOI 10.1016/j.ijantimicag.2026.107994

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

7. Daptomycin-resistant Staphylococcus capitis: Mechanisms, molecular epidemiology, and clinical aspects.

   J Glob Antimicrob Resist · 2026 Sep · PMID 42342121 · DOI 10.1016/j.jgar.2026.06.012

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

8. Effects of Cholesterol and Solution pH on Daptomycin-bilayer Interactions.

   J Membr Biol · 2026 Aug 29 · PMID 42667401 · DOI 10.1007/s00232-026-00400-8

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

9. Population pharmacokinetics of daptomycin in patients with haematological malignancies and vancomycin-resistant Enterococcus bloodstream infections.

   Int J Antimicrob Agents · 2026 Aug 24 · PMID 42637177 · DOI 10.1016/j.ijantimicag.2026.107974

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

10. Daptomycin Overcomes Listeria monocytogenes Persister Cells Through Strain-Dependent Efficacy and clpP-Mediated Stress Response.

    Infect Drug Resist · 2026 · PMID 42609602 · DOI 10.2147/IDR.S569234

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

11. The double-edged sword of daptomycin: a case of daptomycin-induced eosinophilic pneumonia.

    Oxf Med Case Reports · 2026 Aug · PMID 42583159 · DOI 10.1093/omcr/omag146

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

12. Saturated fatty acids enhance daptomycin activity in a Fak-dependent manner in enterococci.

    Microbiology (Reading) · 2026 Aug · PMID 42560741 · DOI 10.1099/mic.0.001751

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

13. Daptomycin pharmacokinetics in critically ill patients receiving extracorporeal membrane oxygenation: A pilot cohort study.

    J Intensive Med · 2026 Aug · PMID 42396240 · DOI 10.1016/j.jointm.2026.02.002

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

14. Daptomycin-Induced Eosinophilic Pneumonia in a Patient Treated for MRSA Foot Infection: A Case Report.

    J Am Podiatr Med Assoc · 2026 Jul 8 · PMID 42496338 · DOI 10.3390/japma116040049

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

15. The DUF998 family protein DrmA modulates cationic glycolipid levels and the emergence of high-level daptomycin resistance in Enterococcus faecalis.

    bioRxiv · 2026 Jul 7 · PMID 42465274 · DOI 10.64898/2026.07.07.736841

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

16. Clinical outcomes of daptomycin in patients with augmented renal clearance: a case series.

    J Infect Chemother · 2026 Jul · PMID 42202984 · DOI 10.1016/j.jiac.2026.103005

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

17. Outcomes and Adverse Events Among Patients with Vancomycin-Resistant Enterococcal Bloodstream Infection Treated with Daptomycin Doses Greater than 12 mg/kg.

    Infect Dis Ther · 2026 Jul · PMID 42171968 · DOI 10.1007/s40121-026-01369-6

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

18. Therapeutic drug monitoring in older adults treated with beta-lactams or daptomycin in a French tertiary hospital: A retrospective study (TEldBet).

    Infect Dis Now · 2026 Jul · PMID 42140588 · DOI 10.1016/j.idnow.2026.105286

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

19. Comparative outcomes of daptomycin and linezolid in vancomycin-resistant enterococcal intra-abdominal infections with bacteraemia.

    Int J Antimicrob Agents · 2026 Jul · PMID 41912120 · DOI 10.1016/j.ijantimicag.2026.107792

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

20. Efficacy and Safety of Daptomycin in the Neonatal Population.

    Pediatr Infect Dis J · 2026 Jul 1 · PMID 41470039 · DOI 10.1097/INF.0000000000005136

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

21. Does daptomycin still have a part to play in the treatment of Enterococcus faecium bacteremia in the intensive care unit?

    Crit Care · 2026 Jun 23 · PMID 42337632 · DOI 10.1186/s13054-026-06152-0

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

22. cGAS/STING sensing in dendritic cells discriminates between daptomycin sensitive and resistant Staphylococcus aureus clinical isolates.

    iScience · 2026 Jun 19 · PMID 42164850 · DOI 10.1016/j.isci.2026.115854

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

23. Treatment outcomes of daptomycin- and vancomycin-resistant Enterococcus faecium bloodstream infection.

    JAC Antimicrob Resist · 2026 Jun · PMID 42290912 · DOI 10.1093/jacamr/dlag108

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

24. Postmodification of Daptomycin at Tryptophan Enables the Discovery of Aryl-Daptomycin Antibiofilm Activity against MRSA.

    J Med Chem · 2026 Jun 11 · PMID 42187104 · DOI 10.1021/acs.jmedchem.6c00470

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

25. Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a "Hit Hard and Fast" Strategy Improve Outcomes?

    Clin Infect Dis · 2026 Jun 9 · PMID 42262084 · DOI 10.1093/cid/ciag228

    Source metadata only · evidence grade unassigned · scientific conclusions pending review